BYDUREON (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the BYDUREON drug offered from AstraZeneca Pharmaceuticals LP. This GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | exenatide |
| SUBSTANCE NAME: | EXENATIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SUSPENSION, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-09-08 |
| END MARKETING DATE: | 0000-00-00 |
BYDUREON HUMAN PRESCRIPTION DRUG Details:
| Item Description | BYDUREON from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/.65mL) |
| START MARKETING DATE: | 2014-09-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-6530_c5d95af9-9f58-4914-8863-0edb666e39a2 |
| PRODUCT NDC: | 0310-6530 |
| APPLICATION NUMBER: | NDA022200 |
Other EXENATIDE Pharmaceutical Manufacturers / Labelers:
